INSP
Inspire Medical Systems, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 8 to May 15 ▼ 3 days of insider sells: $175.9K by 2 insiders, avg $43.58
- Jun 23 ▼ Evercore ISI Group downgrades
- Jul 1 Freedom Capital Markets initiates
- Aug 4 ▲ Oppenheimer upgrades
- Aug 7 ▼ 1 insider sell $57.3K at $59.55
- Oct 7 Barclays initiates
- Nov 2 Inspire Medical Systems reported Q3 2026 revenue of $206.7M, down 7.…
- Nov 2 ▲ Earnings: INSP Q3 2026 Earnings: EPS $0.14 (+161.1% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
3 insiders sold $233.3K.
- InstitutionsBEARISH
Q3 2026: 22 added (2 new), 33 trimmed or exited. Largest new: William Blair Investment Management $44.4M.
- AnalystsMIXED
9 of 24 rate it Buy or better. Median target $69.50 (+18%).
- EstimatesFLAT
Current-quarter EPS estimate $0.912 → $0.916 over 90 days. 4 up, 5 down in 30 days.
- Short sellersSTEADY
Short interest −7.8% to 4.14M shares. 6.6 days to cover, ≈14.3% of shares.
- TrendDOWNTREND
14% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Assenagon Asset Management S.A. | TRIM | $44.6M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | NEW | $44.4M |
| FEDERATED HERMES, INC. | ADD | $33.5M |
| PRINCIPAL FINANCIAL GROUP INC | DOUBLED | $22.3M |
| JPMORGAN CHASE & CO | DOUBLED | $10.2M |
| FRANKLIN TEMPLETON INC | DOUBLED | $9.1M |
| Amundi | DOUBLED | $7.6M |
| FMR LLC | TRIM | $5.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
24 analystsPrice is inside the target range. Median implies +18%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 13, 2026 | Freedom Capital Markets MAINTAIN | Buy |
| Nov 3, 2026 | JP Morgan MAINTAIN | Neutral |
| Nov 3, 2026 | Truist Securities REITERATE | Hold |
| Nov 3, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Nov 3, 2026 | Evercore ISI Group MAINTAIN | In-Line |
| Nov 3, 2026 | Barclays MAINTAIN | Underweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Broader Shelley G Director Oct 14, 2026 | AWARD | $19.3K |
Melenikiotou Georgia Director Oct 14, 2026 | AWARD | $17.4K |
Ellis Gary Lee Director Oct 14, 2026 | AWARD | $29.3K |
CARREL MICHAEL H Director Oct 14, 2026 | AWARD | $13.8K |
Kelly Jason P See Remarks Aug 31, 2026 | AWARD | 6,350 sh |
Kelly Jason P See Remarks Aug 7, 2026 | SELL | $57.3K |
Mann Melissa Chief People Officer Jul 31, 2026 | TAX W/H | $16.4K |
CARREL MICHAEL H Director Jul 20, 2026 | AWARD | 5,631 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.92 | $0.85–$0.97 | +0.4% | $243.7M |
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
16 filings · 0 bullish · 2 bearish · 2 mixed · 12 neutral- NEUTRAL INST-CLUSTERNov 16, 2026
In Q2 2026, 42 institutional buyers accumulated $73.5M in INSP while 31 sellers reduced by $100.3M, resulting in net selling of $26.8M. The buying was dominated by mega-passive funds (UBS, Fidelity, Vanguard) likely rebalancing after the stock's decline, while active managers (Morgan Stanley…
🔒 Fresh report (last 24h), subscribers only
- BEARISH SC 13G/ANov 12, 2026
AQR Capital Management LLC filed an amended Schedule 13G for Inspire Medical Systems, reporting a…
AQR's reduction below 5% removes a significant passive holder from the ownership base. Combined with Soleus Capital also reducing below 5% (reported 3 days prior), two large institutional holders…
- MIXED INST-CLUSTERNov 9, 2026
An institutional cluster for INSP in Q3 2026 shows mixed conviction: 5 buyers added $70.3M in new…
The cluster is split: large new active-manager positions (William Blair, Principal, Amundi) suggest conviction in the long-term CPT code catalyst and raised EPS guidance, but the 9-to-5 seller count…
- BEARISH SC 13G/ANov 9, 2026
Soleus Capital Master Fund filed an amended Schedule 13G for Inspire Medical Systems, reporting a…
Soleus Capital's reduction below 5% removes a passive holder from the 5%+ ownership list. Monitor for any further selling or a potential conversion to a 13D if the fund's intent changes. The filing…
All INSP filing & press-release reports (16)
- INST-CLUSTER reportNov 16, 2026
- SC 13G/A reportNov 12, 2026
- INST-CLUSTER reportNov 9, 2026
- SC 13G/A reportNov 9, 2026
- 8-K reportNov 2, 2026
- PRESS-RELEASE reportNov 2, 2026
- SC 13G/A reportOct 30, 2026
- PRESS-RELEASE reportOct 5, 2026
- 3 reportJul 27, 2026
- 8-K reportJul 24, 2026
- 8-K reportJul 22, 2026
- PRESS-RELEASE reportJul 6, 2026
- INST-CLUSTER reportJun 11, 2026
- 144 reportMay 8, 2026
- PRESS-RELEASE reportApr 6, 2026
- DEFA14A reportMar 20, 2026